Fuzeon Generic Name & Formulations
Legal Class
Rx
General Description
Enfuvirtide 108mg/vial; pwd for SC inj after reconstitution; preservative-free.
Pharmacological Class
Fusion inhibitor.
How Supplied
Kit—1 (60 vials w. supplies)
Manufacturer
Generic Availability
NO
Fuzeon Indications
Indications
Treatment of HIV-1 infection, in combination with other antiretroviral agents, in treatment-experienced patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.
Fuzeon Dosage and Administration
Adult
Give by SC inj into upper arm, anterior thigh, or abdomen (not into moles, scar tissue, bruises, or navel). Rotate inj sites. >16yrs: 90mg twice daily.
Children
<6yrs: limited data available. Give by SC inj into upper arm, anterior thigh, or abdomen (not into moles, scar tissue, bruises, or navel). Rotate inj sites. 6–16yrs: 2mg/kg twice daily; max 90mg twice daily.
Fuzeon Contraindications
Not Applicable
Fuzeon Boxed Warnings
Not Applicable
Fuzeon Warnings/Precautions
Warnings/Precautions
Discontinue if hypersensitivity occurs; do not rechallenge. Instruct patients on proper use of Biojector 2000 needle-free device. Monitor for pneumonia (esp. if low initial CD4 cell count, high initial viral load, IV drug use, history of lung disease, or smoker). Coagulation disorders. Renal insufficiency (CrCl <35mL/min). Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
Fuzeon Pharmacokinetics
See Literature
Fuzeon Interactions
Interactions
Increased risk of post-injection bleed with concomitant anticoagulants. May cause false (+) ELISA test for HIV.
Fuzeon Adverse Reactions
Adverse Reactions
Local inj site reactions, diarrhea, nausea, fatigue; pneumonia, hypersensitivity reactions, immune reconstitution syndrome, autoimmune disorders.
Fuzeon Clinical Trials
See Literature
Fuzeon Note
Notes
Register pregnant patients exposed to enfuvirtide by calling (800) 258-4263.
Fuzeon Patient Counseling
See Literature